SELL and nonpapillary renal cell carcinoma: Moreover, CD3-CD56bright and CD3-CD56dim NK cells from ccRCC patients presented a lower frequency of CD62L+ cells, a finding that was most notorious in CD3-CD56dim cells (Figures 1L, M) and was accompanied by significantly lower expression of CD62L only on CD3-CD56dim NK cells (Figures 1N, O).